Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACHIEVE LIFE SCIENCES, INC. Director's Dealing 2022

Jan 5, 2022

33882_dirs_2022-01-05_4462b61a-949d-4563-afd6-f3fecbbc0411.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2022-01-03

Reporting Person: Bencich John (Director, CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-01-03 Performance Restricted Stock Unit (PRSU) $ A 50000 Acquired 2026-01-03 Common Stock (50000) Direct
2022-01-03 Stock Option (right to buy) $8.26 A 50000 Acquired 2032-01-03 Common Stock (50000) Direct

Footnotes

F1: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.

F2: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The PRSUs will lapse in full if achievement of such milestone is not met.

F3: The options vest one-third on the first anniversary of January 3, 2022 and thereafter in monthly installments over 24 months.